ArticleScientific reports2026
Real-time prediction of influenza and respiratory syncytial virus epidemics in primary care using the Gompertz model.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Seasonal epidemics of influenza and respiratory syncytial virus (RSV)-bronchiolitis pose significant challenges for public health systems, requiring timely predictions for effective interventions. In this study, we applied a Gompertz model to cumulative daily primary care diagnoses in Catalonia to predict epidemic peaks and characterize the dynamics of the disease. We estimated RSV-bronchiolitis cases from all-cause bronchiolitis diagnoses and computed epidemic thresholds for the disease. Our approach allowed for peak predictions up to 32 days in advance with an error margin of one week (anticipated). The estimated magnitudes were within 35% error 28 days before the peak and mostly fell within 95% confidence intervals, except for the irregular 2022-2023 RSV-bronchiolitis post-COVID-19 pandemic season. Influenza epidemics exhibited a faster decline, resulting in more symmetrical curves, whereas RSV-bronchiolitis outbreaks were broader, with a higher initial transmission rate. The model operates in real-time without reliance on external assumptions, making it adaptable to changes in epidemiology. However, human intervention to set the models' parameters enables them to be fitted more precisely, resulting in even better performance through iterative refinement. Our findings highlight the potential of supervised real-time predictive modeling to support epidemic preparedness and optimize healthcare resource allocation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.